✦ LIBER ✦

Ophthalmologic safety of long-term hydroxychloroquine treatment

✍ Scribed by Richard I. Rynes; Gregory Krohel; Anthony Falbo; Robert D. Reinecke; Bruce Wolfe; Lee E. Bartholomew

Book ID: 101644948
Publisher: John Wiley and Sons
Year: 1979
Tongue: English
Weight: 412 KB
Volume: 22
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.1780220805

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term treatment of osteoporosis: saf

Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab

✍ Anastasilakis, Athanasios 📂 Article 📅 2012 🏛 Dove Press Ltd. 🌐 English ⚖ 250 KB

Safety: a long-term view

📂 Article 📅 2012 🏛 Society of Chemical Industry 🌐 English ⚖ 92 KB

Efficiency and Safety of Long-Term Artro

Efficiency and Safety of Long-Term Artrofoon Treatment in Rheumatoid Arthritis

✍ V. I. Petrov; A. R. Babaeva; E. V. Cherevkova; M. V. Kachanova; Yu. A. Zabolotne 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 135 KB

Nicorandil safety in the long-term treat

Nicorandil safety in the long-term treatment of coronary heart disease

✍ Serge Witchitz; Jean-Yves Darmon 📂 Article 📅 1995 🏛 Springer US 🌐 English ⚖ 846 KB

Safety of long-term high-dose minocyclin

Safety of long-term high-dose minocycline in the treatment of acne

✍ V. GOULDEN; D. GLASS; W.J. CUNLIFFE 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 265 KB

Long-term efficacy and safety of deferas

Long-term efficacy and safety of deferasirox

✍ Maria Domenica Cappellini 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Deferasirox is an oral iron chelator, with a long half-life, that can be given once daily, because it provides a 24-hour chelation. Several phase II trials and a pivotal phase III trial have established that, in transfusion-dependent patients with beta-thalassaemia major, deferasirox has a similar e